Short interest in Aligos Therapeutics Inc (NASDAQ:ALGS) increased during the last reporting period, rising from 597.30K to 664.38K. This put 29.56% of the company's publicly available shares short.

Short interest for Aligos Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Aligos Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 427.05K shares traded per day, it would take 1.56 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.